2022 - rct - Pivotal Reference
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
Jastreboff AM et al.. N Engl J Med.
Bibliography For Tirzepatide
Every Curated Peer-Reviewed Reference Indexed For This Compound. Each Citation Can Be Exported In BibTeX, RIS, EndNote, Or Plain Text.
Indexed Types:labelmonographrctstudy
2021 - rct - Pivotal Reference
Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes (SURPASS-2)
Frias JP et al.. N Engl J Med.
n.d. - monograph
RxNorm 2601723 (Tirzepatide)
Unknown Authors.
n.d. - study
Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.
Unknown Authors.
n.d. - study
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study
Unknown Authors.
n.d. - study
Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome.
Unknown Authors.
n.d. - study
Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial.
Unknown Authors.
n.d. - study
Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease.
Unknown Authors.
n.d. - study
Multidimensional Predictors of Tirzepatide Efficacy: Clinical, Genetic, and Molecular Biomarkers for Glycemic, Weight, and Organ Protection.
Unknown Authors.
n.d. - study
Tirzepatide in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification?
Unknown Authors.
n.d. - study
Cutaneous Allodynia Associated With GLP-1RA Tirzepatide for Weight Management: A Case Series.
Unknown Authors.
n.d. - study
GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives.
Unknown Authors.
n.d. - study
Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes.
Unknown Authors.
n.d. - study
Tirzepatide vs. semaglutide for obesity, glycemic control, and cardiovascular outcomes: a narrative review of clinical trials.
Unknown Authors.
n.d. - study
Tirzepatide-associated interstitial kidney injury.
Unknown Authors.
n.d. - study
Alopecia Risk With GLP‐1 Receptor Agonists: A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)
Unknown Authors.
n.d. - study
Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide: a protocol for a randomised controlled trial in a single-centre setting.
Unknown Authors.
n.d. - study
Glucagon-Like Peptide-1 Receptor Agonists Inhibit the Initiation of Toxic Amyloid-β42 Aggregation.
Unknown Authors.
n.d. - study
Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.
Unknown Authors.
n.d. - study
Tirzepatide-associated hyponatremia in a patient with known arginine vasopressin deficiency.
Unknown Authors.
n.d. - study
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.
Unknown Authors.
n.d. - study
Hypercalcemia Induced by Tirzepatide and Calcium Supplementation: A Case Report.
Unknown Authors.
n.d. - study
Health-Related Quality of Life and Work-Related Outcomes in People with Obesity or Overweight Treated with Tirzepatide or Other Obesity Medications: United States Results from the Adelphi Real World Obesity Disease Specific Programme™.
Unknown Authors.
n.d. - study
Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.
Unknown Authors.
n.d. - study
Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6.
Unknown Authors.
n.d. - study
The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials.
Unknown Authors.
n.d. - study
GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling.
Unknown Authors.
n.d. - label
ZEPBOUND (TIRZEPATIDE) INJECTION, SOLUTION ZEPBOUND (TIRZEPATIDE) INJECTION, SOLUTION ZEPBOUND KWIKPEN (TIRZEPATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY]
Unknown Authors.